Cigna announced Monday morning that what it's calling a "new era" for its PBM unit is built on three core elements: ...

Cam Newton knows better than anyone else what it’s like to live in the spotlight as an NFL quarterback. The former MVP recently weighed in on Shedeur Sanders, who faced a lot of scrutiny for in the ...

The Iowa Hawkeyes dropping back down to .500 with a nail-biting home loss to a ranked Indiana Hoosiers team, following a missed chip-shot field goal, is a painful enough reckoning for the black and ...

Critical care nurse Janet Kerrigan was stunned to discover in 2011 that she had multiple myeloma, an incurable blood cancer, and she only had a year or two to live. A crucial stem cell transplant in ...

Trevor Lawrence led the Jacksonville Jaguars to a win over the Kansas City Chiefs in primetime on Monday night. In the final minute of the game, the quarterback stumbled after the ball was snapped ...

INGLEWOOD, CA — Sunday’s game was poetic for Jayden Daniels. After missing the past two games due to a sprained knee, Daniels returned Sunday to his native area and was instrumental to the Washington ...

Drug discovery firm Exscientia has claimed a world first after announcing that the first precision engineered drug generated by artificial intelligence (AI) is entering clinical trials. UK-based ...

Running back D'Andre Swift shares his reaction after being traded to Philadelphia Eagles. PFF NFL Analyst Sam Monson: Los Angeles Rams got 'one of the steals of the draft' in Rams cornerback Tre'Vius ...

GSK has appointed a new boss after announcing the departure of Emma Walmsley following eight years at the helm of the drugmaker. Ms Walmsley was the first woman to run a major pharmaceutical company ...

Bank of America Securities said GoodRx’s long-term outlook will depend on how it adapts to a rapidly evolving prescription drug market, as the Trump administration intensifies efforts to shift pricing ...

TOKYO, October 07, 2025--(BUSINESS WIRE)--RIBOMIC, Inc. (TOKYO:4591), a clinical-stage pharmaceutical company specializing in aptamer therapeutics, has conducted a Phase 2 clinical trial of ...